Beneficial effects of GM1 ganglioside on photochemically-induced microvascular injury in cerebral cortex and hypophysis in rat

Experimental and Toxicologic Pathology

Volumn 52, Issue 2, 2000, Pages 111-118

  Frontczak Baniewicz, Małgorzata ^a   Gadamski, Roman ^b   Barskov, Igor ^c   Gajkowska, Barbara ^a,b  

^a Lab Ultrastructure Nerv Syst   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c BRAIN RESEARCH INSTITUTE   (Russian Federation)

Author keywords

Brain, microcapillaries; Cerebral cortex, microvascular injury; Cerebral ischemia; Ganglioside, GM1; Hypophysis, microvascular injury; Ischemia, cerebral; Microcapillarie, brain; Photochemically induced injury, cerebral cortex, hypophysis; Photochemically reaction; Ultrastructure of brain microcapillaries

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE GM1; GLYCOPHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CAPILLARY; BRAIN ISCHEMIA; BRAIN MICROCIRCULATION; BRAIN NERVE CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; HYPOPHYSIS; MALE; MICROTHROMBUS; NERVE REGENERATION; NONHUMAN; RAT;

ANIMALIA;

EID: 0034080759     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-2993(00)80094-9     Document Type: Article

References (38)

1. BAOWAN L, GINSBERG MD, BUSTO R: Sequential analysis of subacute and chronic neuronal, astrocytic and microglial alterations after transient global ischemia in rats. Acta Neuropathol 1998; 95: 511-523.
2. BARUCHA VA, WAKADE CG, MAHADIK SP, et al.: GM1 ganglioside treatment reduces functional deficits associated with cortical focal ischemia. Exp Neurol 1991; 114: 136-139.
3. BREMER EG, HAKOMORI SL: GM3 ganglioside induces hamster fibroblast growth inhibition in chemically-define medium: Ganglioside may regulate growth factor receptor function. Biochem Biophys Res Commun 1982; 106: 711-718.
4. CUELLO AC, GAROFALO L, KENIGSBERG RL, et al.: Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons. Proc Natl Acad Sci USA 1989; 86: 2056-2060.
5. CUMAR F, MAGGIO B, CAPPUTO R: Dopamine release from nerve endings induced by polysialogangliosides. Biochem Biophys Res Comun 1978; 84: 65-69.
6. DEL ZOPPO GJ: Microvascular changes during cerebral ischemia and reperfusion. Cerebrovasc Brain Metab Rev 1994; 6: 47-96.
7. ELLIOTT PJ, GAROFALO L, CUELLO AC: Limited neocortical devascularizing lesions causing deficits in memory retention and choline acetyltransferase activity. Effects of the monosialoganglioside GM1. Neurosci 1989; 31: 63-76.
8. FAGIOLI S, ROSSI-ARNAUD C, AMASSARI-TEULE M: Open field behaviours and spatial learning performance in C57BL/6 mice: early stage effects of chronic GM1 ganglioside administration. Psychopharmacology 1991; 105: 209-212.
9. FISHMAN P, MOSS J, MANGANIELLO V: Synthesis and uptane of gangliosides by choleragen-responsive human fibroblasts. J Biochem 1977; 16: 1871-1875.
10. GAJKOWSKA B, FRONTCZAK-BANIEWICZ M, GADAMSKI R, et al.: Photochemically-induced vascular damage in brain cortex. Transmission and scanning electron microscopy study. Acta Neurobiol Exp 1997; 57: 203-208.
11. GORIO A, MARINI P, ZANONI R: Muscle reinnervation III. Motor neuron sprouting capacity enhancement by exogenous gangliosides. Neurosci 1983; 3: 417-429.
12. HADJICONSTANTINOU M, KARADSHEH NS, RATTAN AK, et al.: GM1 ganglioside enhances cholinergic parameters in the brain of senescent rats. Neurosci 1992; 46: 681-686.
13. KANDA S, INOUE K, NOJIMA S, et al.: Incoporation of spin-labelled ganglioside analogues into cell and liposomal membranes. J Biochem 1982; 91: 1707-1718.
14. KARPIAK SE: Ganglioside treatment improves recovery of alternation behavior after unilateral entorhinal cortex lesion. Exp Neurol 1983; 81: 330-339.
15. KARPIAK SE: Exogenous gangliosides enhancer recovery from CNS injury. In: Ganglioside structure, function, and biochemical potential. Adv Exp Med Biol 1984; 174: 489-497.
16. KARPIAK SE, MAHADIK SP, WAKADE CG: Ganglioside reduction of ischemic injury. Crit Rev Neurobiol 1990; 5: 221-237.
17. KASARSKIS E, KARPIAK SE, RAPPORT MM, et al.: Abnormal maturation of cerebal cortex and behavior in adult rats after neonatal administration of antibodies to GM1 ganglioside. Brain Res 1981; 227: 25-35.
18. KLEINEBECKEL D: Acceleration of muscle re-innervation in rats by ganglioside treatment: an electromyographic study. Eur J Pharmacol 1982; 80: 243-245.
19. KONTOS H: Oxygen radicals in cerebral vascular injury. Circ Res 1985; 57: 508-516.
20. LIVINGSTON A: Subcellular aspects of storage and release of neurohypophysial hormones. J Endocr 1971; 49: 357-372.
21. LOSSINSKY AS, BADMAJER V, ROBSON JA, et al.: Sites of egress of inflammatory cells and horseradish peroxidase transport across the blood brain barrier in a murine model of chronic relapsing experimental allergic encephalomyelitis. Acta Neuropathol 1989; 78: 359-371.
22. LOSSINSKY AS, VORBRODT AW, WISNIEWSKI HM: Scanning and transmission electron microscopic studies of microvascular pathology in the osmotically impaired blood-brain barrier. J Neuropathol 1995; 24: 795-806.
23. MAHADIK SP, KARPIAK SE: GM1 ganglioside enhances neonatal cortical development. Neurotoxicol 1986; 7: 486-497.
24. 2+-ATPase. J Neurosci Res 1989; 24: 402-419.
25. MOSS JD, FISHMAN VC, MANGANIELLO M, et al.: functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness. Proc Natl Acad Sci USA 1976; 73: 1034-1037.
26. ORTIZ A, MACDONNELL JS, WAKADE CG, et al.: GM1 ganglioside reduces cognitive dysfunction after focal cortical ischemia. Pharmacol Biochem Behav 1990; 37: 679-684.
27. PEPEU G, ODERFELD-NOWAK B, CASAMENTI F: CNS pharmacology of gangliosides. In: Progress in brain research. SVENNERHOLM AK, ASBURY RA, REISFELD K, SANDHOFF K, SUZUKI G, TETTAMANI G, TOFFANO (eds). Elsevier Science Amsterdam 1994; vol. 101L pp 327-335.
28. PETITO CK: Platelet thrombi in experimental cerebral infarction. Stroke 1979; 10: 192-196.
29. PLUTA R, LOSSINSKY AS, WISNIEWSKI HM, et al.: Early blood-brain changes in the rat following transient complete cerebral ischemia induced by cardiac arrest. Brain Res 1994; 664: 41-52.
30. RISAU W, WOLBURG H: Development of the blood-brain barrier. TINS 1990; 13(5): 174-178.
31. ROISEN FJ, BARTFELD H, NAGELE R, et al.. Ganglioside stimulation of axonal sprouting in vitro. Science 1981; 214: 135-150.
32. SCHWARTZ M, SPIRMAN N: Sprouting from chicken embryo dorsal root ganglia induced by nerve growth factor is specifically inhibited by affinity-purified antiganglioside antibodies. Proc Natl Acad Sci USA 1982; 70: 6080-6083.
33. SHIFMANN M: The effects of gangliosides upon recovery of aspartate/glutamatergic synapses in striatum after lesions of the rat sensorimotor cortex. Brain Res 1991; 568: 323-324.
34. SPIEGEL S, KASSIS S, WIELCHECK M, et al.: Direct visualization of redistribution and capping of fluorescent gangliosides in lymphocytes. J Cell Biol 1984; 99: 1575-1581.
35. SPIRMAN N, SELA B, SCHWARTZ M: Antiganglioside antibodies inhibit neurotic outgrowth from regenerating goldfish retinal explants. J Neurochem 1982; 39: 874-877.
36. STEPHENS PH, TAGARI PC, CUELLO AC: Retrograde degeneration of basal forebrain cholinergic neurons after neurotoxin lesion of the neocortex: application of ganglioside GM1. Neurochem Int 1988; 12: 475-481.
37. SUZUKI K: Gangliosides and disease: a review. In: Ganglioside structure, function, and biochemical potential. Adv Exp Med Biol 1984; 174: 407-418.
38. WOJCIK M, ULAS J, ODERFELD-NOWAK B: The stimulating effect of ganglioside injections on the recovery of choline acetyltransferase and acetylocholinesterase activities in the hippocampus of the rat after septal lesion. Neurosci. 1982; 7: 495-499.